Eschler Asset Management’s Immunocore IMCR Stock Holding History

Eschler Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.41M	Hold	80,000	–	–	2.4%	10
2025 Q4	$2.78M	Buy	80,000 +40,000	+100%	+$1.41M	1.87%	14
2025 Q3	$1.45M	Hold	40,000	–	–	1.08%	15
2025 Q2	$1.26M	Buy	+40,000	New	+$1.24M	0.95%	24
2024 Q3	–	Sell	-40,000	Closed	-$2.6M	–	75
2024 Q2	$2.6M	Hold	40,000	–	–	2.04%	12
2024 Q1	$2.6M	Hold	40,000	–	–	1.68%	15
2023 Q4	$2.73M	Buy	40,000 +10,000	+33%	+$520K	2.17%	10
2023 Q3	$1.56M	Sell	30,000 -4,000	-12%	-$237K	1.82%	13
2023 Q2	$2.04M	Sell	34,000 -26,000	-43%	-$1.48M	2.89%	7
2023 Q1	$2.97M	Buy	60,000 +28,000	+88%	+$1.57M	2.34%	13
2022 Q4	$1.83M	Buy	32,000 +12,000	+60%	+$675K	3.46%	8
2022 Q3	$939K	Buy	+20,000	New	+$953K	2.07%	16

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Eschler Asset Management's IMCR Position: Q1 2026 in Review

Eschler Asset Management held its Immunocore (IMCR) position steady in Q1 2026 at 80,000 shares worth $2.41M. The position accounts for 2.4% of the portfolio, ranked #10.

Eschler Asset Management first reported a position in IMCR in Q3 2022 and has held it in 12 quarters since. The position peaked at $2.97M in Q1 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Eschler Asset Management held 80,000 shares of Immunocore worth $2.41M as of Q1 2026.
Eschler Asset Management left its Immunocore share count unchanged in Q1 2026.
Immunocore made up 2.4% of Eschler Asset Management's portfolio in Q1 2026, its #10 holding.
Eschler Asset Management first reported a position in Immunocore in Q3 2022 and has held it in 12 quarters since.
Eschler Asset Management's Immunocore position peaked at $2.97M in Q1 2023.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Eschler Asset Management's 13F filing for Q1 2026, filed 15 May 2026.